Reuters -- Abbott Laboratories Chief Executive Miles White said he maintains a “bias” toward building the non-pharmaceutical side of the company’s business and is still interested in non-pharma acquisitions.
Reuters -- Abbott Laboratories Chief Executive Miles White said he maintains a “bias” toward building the non-pharmaceutical side of the company’s business and is still interested in non-pharma acquisitions.
